$BMY
Price history, market instrument context, member research, and related headlines in one place.
BMY key statistics
NYSEUSD
52-week range
$42.5272%$68.64
Latest session $60.39–$62.25Bristol-Myers Squibb Company (BMY) is a stock instrument quoted on NYSE in USD. The most recently published price is $61.32, up $2.04 (3.44%) from the previous close of $59.28. It has traded between $60.39 and $62.25 in the latest session. Over the past year it has ranged from $42.52 to $68.64, leaving it in the upper half of its 52-week range (72%). Reported volume for the session was 4.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
AstraZeneca held talks with Bristol-Myers through spring, summer - FT — See source for full details.
What should investors do with AstraZeneca and Bristol-Myers after test ballon pops — See source for full details.
Bristol-Myers falls on report there are no talks going on with AstraZeneca — See source for full details.
Analyst Report: Bristol-Myers Squibb Co — See source for full details.
Bristol-Myers Squibb, AstraZeneca deal talks remain active - report — See source for full details.
AstraZeneca shares were slumping while Bristol-Myers Squibb’s stock was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come togethe
Why is Bristol-Myers Squibb stock surging today? — See source for full details.
AstraZeneca and Bristol-Myers Squibb in talks over potential merger - Report — See source for full details.
Notable healthcare headlines for the week: Curium, Bristol-Myers Squibb, and Johnson & Johnson in focus — See source for full details.
Loading $BMY research…